FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
306 letters match. Newest first.
-
DrugsCheap Medicine Shop/www.cheapmedicineshop.com
FDA warned India-based website Cheap Medicine Shop for selling unapproved, misbranded injectable semaglutide to U.S. consumers.
High risk -
DrugsOnline Generic Medicine/www.onlinegenericmedicine.com
FDA warned Online Generic Medicine that its website sells unapproved, misbranded injectable semaglutide to U.S. consumers.
High risk -
DrugsCelmade
FDA warned Celmade over websites selling unapproved, misbranded injectable botulinum toxin products to U.S. consumers.
High risk -
FoodGood Stuff Cacao
FDA warns Good Stuff Cacao that disease claims make its cacao, tea, honey, goji unapproved new drugs.
Low -
FoodVasoCorp, Inc.
FDA says VasoCorp markets NeuropAWAY supplements as unapproved drugs with disease-treatment claims.
High risk -
FoodMineral BioSciences, LLC
Mineral BioSciences’ Totala and Ionicell supplements were flagged as unapproved new drugs and misbranded, with manufacturing violations.
High risk -
DrugsKetacyn Pharmaceuticals / www.ketacynpharma.com
FDA told Ketacyn Pharmaceuticals to stop selling unapproved ketamine injection and ketamine gummies to U.S. consumers online.
High risk -
DrugsExtra Medication / www.extramedication.com
FDA warned website Extra Medication for selling unapproved, misbranded ketamine drugs to U.S. consumers without prescriptions.
High risk -
DrugsPure Arylcyclohexylamine Store / www.arylcyclohexylamine.com
FDA warned Pure Arylcyclohexylamine Store it sells unapproved, misbranded ketamine drugs, including an injectable, to U.S. consumers online.
High risk -
DrugsAll Ketamine HCL / www.allketaminehcl.com
FDA warned website All Ketamine HCL for selling unapproved, misbranded ketamine drugs online without prescriptions.
High risk -
DrugsKetamine Troche Store / www.ketaminetrochestore.com
FDA warned online seller Ketamine Troche Store that its website sells unapproved, misbranded ketamine drugs without prescriptions.
High risk -
DrugsBuy Keta Online / www.buyketaonline.com
FDA warns Buy Keta Online that its website sells unapproved and misbranded ketamine drugs to U.S. consumers.
High risk -
DrugsKetamine Store / www.ketaminestore.org
FDA warned website Ketamine Store for selling unapproved, misbranded ketamine liquid and compounded products online without prescriptions.
High risk -
DrugsLegit Ketamine Suppliers / www.legitketaminesuppliers.com
FDA warns Legit Ketamine Suppliers website for selling unapproved, misbranded ketamine and esketamine drugs to U.S. consumers.
High risk -
DrugsKetdaxandrugs / www.ketdaxandrugs.org
FDA warned Ketdaxandrugs it sells unapproved, misbranded ketamine "KETAMINE CRYSTAL" online without prescriptions to U.S. consumers.
High risk -
Drugsketaminetroches.com
FDA warns ketaminetroches.com that it sells unapproved and misbranded ketamine troches to U.S. consumers online.
High risk -
DrugsMed Shop Inc / www.medshopinc.com
FDA warned Med Shop Inc that its website sells unapproved, misbranded ketamine nasal spray to U.S. consumers.
High risk -
DrugsLyfeUnit / www.lyfeunit.com
FDA warns LyfeUnit website for selling unapproved, misbranded ketamine vials to U.S. consumers.
High risk -
DrugsKeta Med Lab / www.ketamedlab.com
Keta Med Lab's website sold unapproved, misbranded ketamine liquid, troches and nasal spray to U.S. consumers without prescriptions, FDA says.
High risk -
DrugsKet Plug / ketaminelab.org and buyketaminepowderonline.com
FDA warns Ket Plug that its ketamine websites sell unapproved, misbranded ketamine powder to U.S. consumers.
High risk -
FoodImu-Tek Animal Health, Incorporated
FDA warns Imu-Tek Animal Health over unapproved drug claims and manufacturing failures for Colostrom-5 products.
High risk -
BiologicsBlue Horizon International, LLC
FDA warned Blue Horizon International over unapproved stem cell and exosome biologics marketed for serious diseases without a license.
High risk -
FoodMeta Labs Pharmaceuticals, LLC
FDA warns Meta Labs its supplements are unapproved drugs and have serious manufacturing violations.
High risk -
FoodOptiHealth Products, Inc.
FDA warned OptiHealth Products over website claims that Super Antioxidant (OPCXtra) is a drug for diseases like diabetes and Alzheimer's.
Low -
DrugsProRx LLC
ProRx LLC, an outsourcing facility, made sterile compounded drugs under insanitary conditions and without required 503B eligibility.
High risk -
FoodNature’s Elements, Inc.
Nature's Elements sold supplement powders with disease claims as unapproved drugs and made them with no required manufacturing records, FDA says.
High risk -
FoodIntelligent Remedies, Inc.
FDA warned Intelligent Remedies that disease-treatment claims make nine products unapproved new drugs.
High risk -
FoodDiamond-Herpanacine of PA, Inc.
FDA says Diamond-Herpanacine supplement claims make its eye and skin products unapproved drugs.
Low -
FoodSupersmart USA, LLC
FDA says Supersmart USA sold dietary supplements with disease-treatment claims, making them unapproved and misbranded drugs.
Low -
FoodNupack Inc.
FDA warned Nupack Inc. that its dietary supplements were unapproved drugs and made without required manufacturing-practice records.
High risk -
DrugsThrive Health and Wellness, LLC dba Thrive Health Solutions
FDA warned Thrive Health and Wellness, a Colorado repackager, that sterile drugs were made in unsanitary conditions and sold without approval.
High risk -
DrugsBeauty of Aztlan LLC
FDA warns Beauty of Aztlan it sells unapproved, misbranded injectable botulinum toxin drugs online to U.S. consumers.
High risk -
DrugsDry Springs Pharmacy
FDA warned Dry Springs Pharmacy that its website sells unapproved and misbranded opioids, benzodiazepines, and stimulants to U.S. consumers.
High risk -
DrugsOnline Rx Medz
FDA warns Online Rx Medz for selling unapproved, illegally labeled opioids, benzodiazepines, and stimulants online.
High risk -
DrugsRxgoodusa
FDA warned Rxgoodusa that its website sells unapproved, misbranded opioid and benzodiazepine drugs to U.S. consumers without prescriptions.
High risk -
FoodHalf Hill Farm Inc.
FDA cited Half Hill Farm's mushroom extracts as unapproved new drugs over website disease-treatment claims.
Low -
DrugsImmunityBio, Inc.
FDA says ImmunityBio's Anktiva TV ad and podcast falsely claim it can cure or prevent all cancers.
High risk -
DrugsCitra100mg
FDA warns Citra100mg it sells unapproved, misbranded tramadol opioids without prescriptions to U.S. consumers online.
High risk -
BiologicsDynamic Stem Cell Therapy
FDA warned Dynamic Stem Cell Therapy that its umbilical cord-derived stem cell product is an unapproved, unlicensed, misbranded biological drug.
High risk -
DrugsMedisourceRx
MedisourceRx failed to report a serious adverse event and had inadequate procedures, so its compounded drugs lost legal exemptions.
Medium -
DevicesASP Global, LLC. dba Anatomy Supply Partners, LLC.
FDA cites ASP Global for quality-system, reporting, and unapproved-change violations involving Safe-T-Fill blood collection devices.
High risk -
DrugsDarmerica, LLC
FDA warns Darmerica over manufacturing-quality violations and mislabeled drug ingredients, including retatrutide.
High risk -
DrugsDermaRite Industries, LLC
DermaRite failed CGMP and sold unapproved, misbranded OTC topical drugs, FDA says.
High risk -
DrugsKorea Filler Experts
FDA warned Korea Filler Experts that its website sells unapproved and misbranded injectable botulinum toxin drugs, including Nabota 100UI, to U.S. consumers.
High risk -
DrugsCosmenic
FDA warned Panama-based Cosmenic that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.
High risk -
DrugsDermacare dba Filler Outlet
South Korea's Dermacare, doing business as Filler Outlet, sells unapproved, misbranded injectable botulinum toxin to U.S. consumers through its website.
High risk -
DrugsMaypharm
Maypharm website sells unapproved, misbranded Botulax botulinum toxin to U.S. consumers, FDA says.
High risk -
DrugsEstaderma
FDA warned South Korea's Estaderma that its website sells unapproved, misbranded injectable botulinum toxin (Liztox) to U.S. consumers.
High risk -
DrugsKorean Aesthetic dba Korean Fillers
FDA warned Korean Fillers that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.
High risk -
DrugsCelestaPro
FDA told CelestaPro its website sells unapproved, misbranded injectable botulinum toxin drugs, including "Nabota 200 Unit", to U.S. consumers.
High risk